There are 413 resources available
225P - Platinum-based chemotherapy and PARP Inhibitors for BRCA mutated metastatic breast cancer (LATER-BC): retrospective multicentre analysis of post-progression treatments
Presenter: Carmine Valenza
Session: Poster viewing and lunch
226P - Treatment Patterns and Comorbidities in Patients With HR+/HER2- MBC: A Real-World Study in Five European Countries
Presenter: Reshma L. Mahtani
Session: Poster viewing and lunch
227P - Molecular landscape of patients with early relapsed metastatic triple-negative breast cancer
Presenter: Thomas Grinda
Session: Poster viewing and lunch
228P - The impact of initial tumor response to docetaxel, trastuzumab, and pertuzumab on survival outcomes of patients with HER2+ metastatic breast cancer: an exploratory analysis of the CLEOPATRA trial.
Presenter: Guilherme Nader Marta
Session: Poster viewing and lunch
230P - Clinical outcomes of cyclin-dependent kinase 4-6 (CDK 4-6) inhibitors in patients with male breast cancer: a multicenter study
Presenter: Hasan Yildirim
Session: Poster viewing and lunch
231P - Trastuzumab Deruxtecan for the treatment of metastatic breast cancer in the UK: real world data
Presenter: Andy Cheng
Session: Poster viewing and lunch
232P - Real World Study of Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer in the United Kingdom
Presenter: Daire Hanna
Session: Poster viewing and lunch
233P - Treatment pattern and outcomes for the first two lines of chemotherapy in patients diagnosed with metastatic triple negative breast cancer, results from the Dutch SONABRE Registry
Presenter: Sandra Geurts
Session: Poster viewing and lunch
234P - Real-World Treatment Patterns and Outcomes of Patients Receiving Palbociclib Plus Endocrine Therapy in Spain: Subgroup Analysis Based on Age, Sites and number of Metastatic locations, menopausal status and dose received from PALBOSPAIN Study
Presenter: Fernando Moreno Anton
Session: Poster viewing and lunch
236P - Trastuzumab deruxtecan in italian real-world experience: updated analysis from DE-REAL study
Presenter: Andrea Botticelli
Session: Poster viewing and lunch